Chembio Diagnostics awarded $12.7 million by BARDA for development of Rapid DPP Respiratory Antigen Panel and 510(k) submission of the Rapid DPP SARS-CoV-2 Antigen test system

Chembio Diagnostics wins $12.7 million from BARDA to develop Rapid DPP Respiratory Antigen Panel. (Credit: Pixabay/Daniel Roberts.)



Related Article
Recommended Whitepaper

View More